Other

Comprehensive Income Including Noncontrolling Interest

Medtronic Comprehensive Income Including Noncontrolling Interest decreased by 35.8% to $1.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 36.0%, from $1.71B to $1.10B.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID: isrg_comprehensive_income_including_noncontrolling_interest

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$1.04B$1.48B$1.65B$1.26B$11.00M$405.00M$622.00M$1.21B$1.26B$957.00M$1.44B$1.71B$729.00M$1.71B$1.10B
QoQ Change+42.2%+10.9%-23.7%-99.1%>999%+53.6%+93.9%+4.2%-23.9%+50.4%+19.0%-57.4%+134.0%-35.8%
YoY Change+20.3%-99.3%-75.4%-50.4%>999%+210.4%+53.9%+19.3%+36.2%-23.8%+18.6%-36.0%
Range$11.00M$1.71B
CAGR+1.4%
Avg YoY Growth+911.4%
Median YoY Growth+18.9%

Comprehensive Income Including Noncontrolling Interest at Other Companies

Frequently Asked Questions

What is Medtronic's comprehensive income including noncontrolling interest?
Medtronic (MDT) reported comprehensive income including noncontrolling interest of $1.10B in Q4 2025.
How has Medtronic's comprehensive income including noncontrolling interest changed year-over-year?
Medtronic's comprehensive income including noncontrolling interest decreased by 36.0% year-over-year, from $1.71B to $1.10B.